Harte Hanks (HHS) director granted 27,861 RSU shares in 2025 filing

Rhea-AI Filing Summary

Harte Hanks Inc director Genevieve Combes reported an equity grant of company stock. On 12/09/2025 she was awarded 27,861 restricted stock unit (RSU) shares of common stock at $3.23 per share, scheduled to vest 100% on the first anniversary of the grant date.

After this award, she beneficially owns 26,283 common shares directly, plus 27,861 RSU shares from the 2025 grant, 12,048 RSU shares granted on 5/23/2024 that vested on 5/23/2025, and 16,216 RSU shares granted on 8/17/2023 that vested on 8/17/2024, with receipt of the vested RSU shares deferred until a later date.

Insider Trade Summary

4 transactions reported

Mixed 4 txns

Insider Combes Genevieve Claire

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	27,861	$3.23	$90K
holding	Common Stock	--	--	--
holding	Common Stock	--	--	--
holding	Common Stock	--	--	--

Holdings After Transaction: Common Stock — 27,861 shares (Indirect, RSU shares held by Harte Hanks, granted to the participant but not yet vested); Common Stock — 26,283 shares (Direct)

Footnotes (1)

1. Participant was granted 27,861 RSU shares on 12/09/2025 that will vest 100% on the first anniversary of the grant date. Participant was granted 12,048 RSU shares on 5/23/2024 that vested 100% on 5/23/.2025, but the participant chose to defer receipt of the vested shares until a later date. Participant was granted 16,216 RSU shares on 8/17/2023 that vested 100% on 8/17/2024, but the participant chose to defer receipt of the vested shares until a later date.

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Combes Genevieve Claire

(Last) (First) (Middle)

1 EXECUTIVE DRIVE, SUITE 303

(Street)

CHELMSFORD MA 01824

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
HARTE HANKS INC [ HHS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
12/09/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	12/09/2025		A		27,861	A	$3.23	27,861(1)	I	RSU shares held by Harte Hanks, granted to the participant but not yet vested
Common Stock								12,048(2)	I	RSU shares held by Harte Hanks, granted to the participant but not yet vested
Common Stock								26,283	D
Common Stock								16,216(3)	I	RSU shares held by Harte Hanks, granted to the participant but not yet vested

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Participant was granted 27,861 RSU shares on 12/09/2025 that will vest 100% on the first anniversary of the grant date.

2. Participant was granted 12,048 RSU shares on 5/23/2024 that vested 100% on 5/23/.2025, but the participant chose to defer receipt of the vested shares until a later date.

3. Participant was granted 16,216 RSU shares on 8/17/2023 that vested 100% on 8/17/2024, but the participant chose to defer receipt of the vested shares until a later date.

Remarks:

	/s/ Robert Wyman, Attorney-in-fact for Genevieve Combes	12/15/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Harte Hanks (HHS) report on 12/09/2025?

On 12/09/2025, director Genevieve Combes was awarded 27,861 RSU shares of Harte Hanks common stock at $3.23 per share, vesting in full one year after the grant date.

How many Harte Hanks (HHS) RSU shares did Genevieve Combes receive in the latest grant?

Genevieve Combes received 27,861 restricted stock unit (RSU) shares of Harte Hanks common stock in the grant dated 12/09/2025.

What are the vesting terms of the 27,861 Harte Hanks (HHS) RSU shares granted in December 2025?

The 27,861 RSU shares granted on 12/09/2025 will vest 100% on the first anniversary of the grant date.

How many Harte Hanks (HHS) common shares does Genevieve Combes own after this transaction?

Following the reported grant, Genevieve Combes owns 26,283 common shares directly, in addition to several RSU positions reported as indirect beneficial ownership.

What prior Harte Hanks (HHS) RSU grants remain deferred for Genevieve Combes?

She has 12,048 RSU shares granted on 5/23/2024 that vested on 5/23/2025, and 16,216 RSU shares granted on 8/17/2023 that vested on 8/17/2024, with receipt of both awards deferred until a later date.

Is the 12/09/2025 Harte Hanks (HHS) RSU grant reported as a direct or indirect holding?

The 27,861 RSU shares granted on 12/09/2025 are reported as indirect beneficial ownership, described as RSU shares held by Harte Hanks and granted to the participant but not yet vested.